• Neurocrine Biosciences Chief Human Resources Officer Julie Cooke exercised stock options for 24,965 shares at $81.49 on June 2, 2026.
• Cooke sold 36,937 shares on June 2 at weighted average prices ranging from $154.83 to $158.59.
• Beneficial ownership fell to 22,374 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001776977-26-000010), on June 04, 2026, and is solely responsible for the information contained therein.